Upcoming Events at Cinghiale
Description
Anti-tumor antibiotics, Topoisomerase inhibitors, Mitotic inhibitors, IMiDs & Proteasome inhibitors
Event Details
Greetings,
We are pleased to present the next part of our seminar lecture series, "Anti-tumor antibiotics, Topoisomerase inhibitors, Mitotic inhibitors, IMiDs & Proteasome inhibitors." This unique educational approach is designed to cover chemotherapeutic agents from mechanisms of action to day-to-day Hematology and Oncology clinical practice. This lecture will be beneficial for Medical Oncologists, Hematologists, Hematology/Oncology Fellows, Researchers, Nurse Practitioners, and Pharmacists.
We look forward to you joining us on Wednesday, November 30, 2022, for this unprecedented and unique lecture series about onco-pharmacology.
Target audience: Medical Oncologists, Hematologists, Hematology/ Oncology Fellows, Researchers, Nurse Practitioners, & Pharmacists
Learning Objectives:
To recognize and understand the chemistry and mechanism of action of different classes of chemotherapeutic agents that are currently used in modern oncology
To review the clinical indication of small molecule and biologic based chemotherapeutic agents
To understand the major adverse event profiles and management of chemotherapeutic agents
To review pharmacology related hematology and medical oncology board questions
We are pleased to present the next part of our seminar lecture series, "Anti-tumor antibiotics, Topoisomerase inhibitors, Mitotic inhibitors, IMiDs & Proteasome inhibitors." This unique educational approach is designed to cover chemotherapeutic agents from mechanisms of action to day-to-day Hematology and Oncology clinical practice. This lecture will be beneficial for Medical Oncologists, Hematologists, Hematology/Oncology Fellows, Researchers, Nurse Practitioners, and Pharmacists.
We look forward to you joining us on Wednesday, November 30, 2022, for this unprecedented and unique lecture series about onco-pharmacology.
Target audience: Medical Oncologists, Hematologists, Hematology/ Oncology Fellows, Researchers, Nurse Practitioners, & Pharmacists
Learning Objectives:
To recognize and understand the chemistry and mechanism of action of different classes of chemotherapeutic agents that are currently used in modern oncology
To review the clinical indication of small molecule and biologic based chemotherapeutic agents
To understand the major adverse event profiles and management of chemotherapeutic agents
To review pharmacology related hematology and medical oncology board questions
